vs

Side-by-side financial comparison of CROSS COUNTRY HEALTHCARE INC (CCRN) and QUALYS, INC. (QLYS). Click either name above to swap in a different company.

CROSS COUNTRY HEALTHCARE INC is the larger business by last-quarter revenue ($236.8M vs $175.3M, roughly 1.4× QUALYS, INC.). QUALYS, INC. runs the higher net margin — 30.3% vs -35.0%, a 65.3% gap on every dollar of revenue. On growth, QUALYS, INC. posted the faster year-over-year revenue change (10.1% vs -23.6%). QUALYS, INC. produced more free cash flow last quarter ($74.9M vs $16.1M). Over the past eight quarters, QUALYS, INC.'s revenue compounded faster (9.6% CAGR vs -21.0%).

GE Healthcare Technologies, Inc. is an American health technology company based in Chicago, Illinois. The company, which stylizes its own name as GE HealthCare, operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical ...

Qualys, Inc. is an American technology firm based in Foster City, California, specializing in cloud security, compliance and related services.

CCRN vs QLYS — Head-to-Head

Bigger by revenue
CCRN
CCRN
1.4× larger
CCRN
$236.8M
$175.3M
QLYS
Growing faster (revenue YoY)
QLYS
QLYS
+33.7% gap
QLYS
10.1%
-23.6%
CCRN
Higher net margin
QLYS
QLYS
65.3% more per $
QLYS
30.3%
-35.0%
CCRN
More free cash flow
QLYS
QLYS
$58.8M more FCF
QLYS
$74.9M
$16.1M
CCRN
Faster 2-yr revenue CAGR
QLYS
QLYS
Annualised
QLYS
9.6%
-21.0%
CCRN

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
CCRN
CCRN
QLYS
QLYS
Revenue
$236.8M
$175.3M
Net Profit
$-82.9M
$53.1M
Gross Margin
83.4%
Operating Margin
-30.2%
33.6%
Net Margin
-35.0%
30.3%
Revenue YoY
-23.6%
10.1%
Net Profit YoY
-2109.7%
20.9%
EPS (diluted)
$-2.56
$1.47

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CCRN
CCRN
QLYS
QLYS
Q4 25
$236.8M
$175.3M
Q3 25
$250.1M
$169.9M
Q2 25
$274.1M
$164.1M
Q1 25
$293.4M
$159.9M
Q4 24
$309.9M
$159.2M
Q3 24
$315.1M
$153.9M
Q2 24
$339.8M
$148.7M
Q1 24
$379.2M
$145.8M
Net Profit
CCRN
CCRN
QLYS
QLYS
Q4 25
$-82.9M
$53.1M
Q3 25
$-4.8M
$50.3M
Q2 25
$-6.7M
$47.3M
Q1 25
$-490.0K
$47.5M
Q4 24
$-3.8M
$44.0M
Q3 24
$2.6M
$46.2M
Q2 24
$-16.1M
$43.8M
Q1 24
$2.7M
$39.7M
Gross Margin
CCRN
CCRN
QLYS
QLYS
Q4 25
83.4%
Q3 25
20.4%
83.6%
Q2 25
20.4%
82.4%
Q1 25
20.0%
81.9%
Q4 24
81.8%
Q3 24
20.4%
81.3%
Q2 24
20.8%
82.2%
Q1 24
20.4%
81.3%
Operating Margin
CCRN
CCRN
QLYS
QLYS
Q4 25
-30.2%
33.6%
Q3 25
-2.4%
35.3%
Q2 25
-2.1%
31.3%
Q1 25
-0.3%
32.4%
Q4 24
-1.1%
31.0%
Q3 24
0.9%
29.2%
Q2 24
-5.7%
32.3%
Q1 24
0.8%
30.7%
Net Margin
CCRN
CCRN
QLYS
QLYS
Q4 25
-35.0%
30.3%
Q3 25
-1.9%
29.6%
Q2 25
-2.4%
28.8%
Q1 25
-0.2%
29.7%
Q4 24
-1.2%
27.6%
Q3 24
0.8%
30.0%
Q2 24
-4.7%
29.4%
Q1 24
0.7%
27.2%
EPS (diluted)
CCRN
CCRN
QLYS
QLYS
Q4 25
$-2.56
$1.47
Q3 25
$-0.15
$1.39
Q2 25
$-0.20
$1.29
Q1 25
$-0.02
$1.29
Q4 24
$-0.13
$1.19
Q3 24
$0.08
$1.24
Q2 24
$-0.47
$1.17
Q1 24
$0.08
$1.05

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CCRN
CCRN
QLYS
QLYS
Cash + ST InvestmentsLiquidity on hand
$108.7M
$250.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$322.8M
$561.2M
Total Assets
$449.0M
$1.1B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CCRN
CCRN
QLYS
QLYS
Q4 25
$108.7M
$250.3M
Q3 25
$99.1M
$225.3M
Q2 25
$81.2M
$194.0M
Q1 25
$80.7M
$290.7M
Q4 24
$81.6M
$232.2M
Q3 24
$64.0M
$235.4M
Q2 24
$69.6M
$281.2M
Q1 24
$5.2M
$273.8M
Stockholders' Equity
CCRN
CCRN
QLYS
QLYS
Q4 25
$322.8M
$561.2M
Q3 25
$408.1M
$529.4M
Q2 25
$412.2M
$508.2M
Q1 25
$418.2M
$498.0M
Q4 24
$419.0M
$477.1M
Q3 24
$424.7M
$449.6M
Q2 24
$433.3M
$427.8M
Q1 24
$462.4M
$404.2M
Total Assets
CCRN
CCRN
QLYS
QLYS
Q4 25
$449.0M
$1.1B
Q3 25
$538.2M
$1.0B
Q2 25
$553.8M
$999.5M
Q1 25
$576.2M
$996.5M
Q4 24
$589.3M
$973.5M
Q3 24
$597.4M
$908.3M
Q2 24
$602.9M
$876.6M
Q1 24
$648.4M
$861.8M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CCRN
CCRN
QLYS
QLYS
Operating Cash FlowLast quarter
$18.2M
$75.7M
Free Cash FlowOCF − Capex
$16.1M
$74.9M
FCF MarginFCF / Revenue
6.8%
42.8%
Capex IntensityCapex / Revenue
0.9%
0.4%
Cash ConversionOCF / Net Profit
1.42×
TTM Free Cash FlowTrailing 4 quarters
$40.1M
$304.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CCRN
CCRN
QLYS
QLYS
Q4 25
$18.2M
$75.7M
Q3 25
$20.1M
$90.4M
Q2 25
$4.2M
$33.8M
Q1 25
$5.7M
$109.6M
Q4 24
$24.2M
$47.7M
Q3 24
$7.5M
$61.0M
Q2 24
$82.4M
$49.8M
Q1 24
$6.0M
$85.5M
Free Cash Flow
CCRN
CCRN
QLYS
QLYS
Q4 25
$16.1M
$74.9M
Q3 25
$17.9M
$89.5M
Q2 25
$2.3M
$32.4M
Q1 25
$3.8M
$107.5M
Q4 24
$21.7M
$41.9M
Q3 24
$6.3M
$57.6M
Q2 24
$79.6M
$48.8M
Q1 24
$3.8M
$83.5M
FCF Margin
CCRN
CCRN
QLYS
QLYS
Q4 25
6.8%
42.8%
Q3 25
7.2%
52.7%
Q2 25
0.8%
19.8%
Q1 25
1.3%
67.3%
Q4 24
7.0%
26.3%
Q3 24
2.0%
37.4%
Q2 24
23.4%
32.8%
Q1 24
1.0%
57.2%
Capex Intensity
CCRN
CCRN
QLYS
QLYS
Q4 25
0.9%
0.4%
Q3 25
0.9%
0.5%
Q2 25
0.7%
0.8%
Q1 25
0.6%
1.3%
Q4 24
0.8%
3.7%
Q3 24
0.4%
2.2%
Q2 24
0.8%
0.7%
Q1 24
0.6%
1.4%
Cash Conversion
CCRN
CCRN
QLYS
QLYS
Q4 25
1.42×
Q3 25
1.80×
Q2 25
0.71×
Q1 25
2.31×
Q4 24
1.09×
Q3 24
2.92×
1.32×
Q2 24
1.14×
Q1 24
2.23×
2.15×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CCRN
CCRN

Temporary Staffing Services$189.6M80%
Physician Staffing$42.5M18%
Other Services$4.7M2%

QLYS
QLYS

Sales Channel Through Intermediary$88.6M51%
Sales Channel Directly To Consumer$86.7M49%

Related Comparisons